(12-358) Evaluating the Impact of a Pharmacy-led Initiative to Incorporate Sodium-glucose cotransporter-2 Inhibitors in the Prescribing Protocol for Patients with Heart Failure with Reduced Ejection Fraction
Wednesday, December 7, 2022
2:00 PM – 3:00 PM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Cardiology/Anticoagulation
